Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
11/1995
11/15/1995EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof
11/15/1995EP0420913B1 Heterofunctional cellular immunological reagents, vaccines containing same and methods for the use of same
11/10/1995CA2148301A1 Expression of recombinant mpf-4, cpf-4, pf-4 and precursor compounds
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995029938A1 Antigen/antibody specificity exchanger
11/09/1995WO1995029700A1 Synthetic vaccine for protection against human immunodeficiency virus infection
11/09/1995CA2537374A1 Density enhanced protein tyrosine phosphatases
11/09/1995CA2189045A1 Synthetic vaccine for protection against human immunodeficiency virus infection
11/08/1995EP0680513A1 Lysosomal targeting of immunogens
11/08/1995CN1111158A Products containing G-CSF and TNF binding protein
11/02/1995WO1995029243A1 Mac-1 i-domain protein useful in blocking adhesion and migration of neutrophils
11/02/1995WO1995029188A1 Human sperm diagnostic
11/02/1995EP0679717A2 Soluble interferon -receptor, its preparation and use
11/02/1995EP0679191A1 Detection and treatment of mutations in a cd40 ligand gene
11/02/1995EP0679186A1 Monokine mig induced by ifn-gamma
11/02/1995EP0679094A1 Compounds for targeting
11/02/1995EP0679089A1 Methods for promoting cartilage matrix formation
11/02/1995CA2188397A1 Human sperm diagnostic
10/1995
10/31/1995US5463029 Adsorbing, eluting on cationic exchange resin, followed by same on anionic exchange resin
10/31/1995US5463028 Compound comprising a methyl ecgonine group chemically attached to a phenylphosphonic group which is an analog to an intermediate of the hydrolysis transition-state of a cocaine benzoyl ester group
10/26/1995WO1995028494A1 Gene delivery fusion proteins
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187818A1 Gene delivery fusion proteins
10/25/1995EP0678122A1 Recombinant anti-vla4 antibody molecules
10/25/1995EP0678102A1 Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein
10/25/1995EP0433378B1 ALLELIC VARIANTS OF $i(PLASMODIUM FALCIPARUM) MEROZOITE SURFACE ANTIGEN
10/25/1995EP0294392B1 Diagnostic and therapeutic antibody conjugates
10/24/1995US5460947 Apolipoprotein B-specific monoclonal antibodies produced by two novel hybridomas
10/19/1995WO1995027787A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995WO1995027782A1 Peptide production as fusion protein in transgenic mammal milk
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995CA2635998A1 Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
10/19/1995CA2187173A1 Peptide production as fusion protein in transgenic mammal milk
10/18/1995EP0677533A2 Antibodies against epitopes with homology to self antigens, methods of preparation and applications thereof
10/17/1995US5459051 Genetic engineering, gene expression
10/17/1995US5459043 Hybridoma CT43 producing a monoclonal antibody to a novel mucin epitope which correlates with the presence of colorectal cancer
10/17/1995US5458878 P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity
10/12/1995WO1995027061A1 Protein tyrosine kinase agonist antibodies
10/12/1995WO1995027059A1 Afamin: a human serum albumin-like protein
10/12/1995WO1995027057A1 GENE CODING FOR IgG-Fc-BINDING PROTEIN
10/12/1995CA2186516A1 Afamin: a human serum albumin-like protein
10/11/1995EP0676413A2 Interferon-alpha/beta binding protein, its preparation and use
10/11/1995EP0460167B1 Humanised antibodies
10/11/1995EP0397700B1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen
10/11/1995CN1029989C Method for preparing the xenogeneic albumen from streptomyces
10/10/1995US5457047 DNA Sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/10/1995US5457033 Producing polypeptide with methionine residue at amino end and glycine residue at carboxyl end by recombinant DNA methods, enzymatically cleaving to polypeptide carboxamide
10/10/1995CA1337283C Method for the selective cleavage of fusion proteins
10/05/1995WO1995026365A1 Synthetic peptide based immunogens for the treatment of allergy
10/05/1995WO1995026200A1 Enhanced virus-mediated dna transfer
10/05/1995WO1995026199A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/05/1995WO1995026196A1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
10/05/1995CA2186856A1 Chimeric infectious bursal disease virus cdna clones, expression products and vaccines based thereon
10/05/1995CA2186595A1 Synthetic peptide based immunogens for the treatment of allergy
10/05/1995CA2186496A1 Covalent dimers of kit ligand and flt-3/flk-2 ligand
10/04/1995EP0675200A1 A FAS ligand, a fragment thereof and DNA encoding the same
10/04/1995EP0674734A1 Runway-maintenance device.
10/04/1995EP0674710A1 Peptides and anti-sense peptides with broad neoplastic specificity
10/04/1995EP0547059B1 Pancreas-elastasis-1-specific antibody, a process for obtaining it and a test kit containing such antibodies
10/04/1995EP0529019B1 Nematode vaccine
10/04/1995EP0271577B1 Immunomodulating compositions and their use
10/04/1995CN1109505A Interferon-alpha/beta binding protein, its preparation and use
10/03/1995US5455337 Treatment of asthma, helminth infections
10/03/1995US5455329 DNA sequences coding for PTH variants, PTH variants, expression vector, bacterial host, use and therapeutic composition
10/03/1995US5455179 Quantitative analysis using polypeptide
10/03/1995US5455158 Imaging fibrin-containing substance using labeled polypeptide imaging agent which binds to fibrin
10/03/1995US5455031 Polypeptide with 46 Kdalton HMFG differentiation antigen binding specificity, composition, kit and diagnostic method
09/1995
09/28/1995WO1995025809A1 Compacted nucleic acids and their delivery to cells
09/28/1995WO1995025795A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS
09/27/1995EP0674178A2 Cyclosporin immunoassay
09/27/1995EP0673428A1 Identification of compounds modulations protein/cell membrane association
09/27/1995EP0673427A1 Process for immobilizing enzymes to the cell wall of a microbial cell by producing a fusion protein
09/27/1995EP0673391A1 Activation-dependent protein expressed on the surface of activated platelets and antibodies thereto
09/27/1995EP0261225B1 Lectin complex and method and probe for making same
09/26/1995US5453354 Method for improving sperm motility
09/26/1995CA1337120C Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccines containing same
09/22/1995CA2144936A1 Antibody conjugates with improved properties
09/20/1995EP0672685A2 Monoclonal antibody
09/20/1995EP0672253A1 Carcinoma associated antigen (sk1) monoclonal antibodies against sk1, methods of producing these antibodies and use therfor
09/20/1995EP0672152A1 Fusion proteins comprising mgf and il-3
09/20/1995EP0672143A1 LYMPHOTOXIN-$g(b), LYMPHOTOXIN-$g(b) COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
09/20/1995EP0672142A1 Multivalent and multispecific binding proteins, their manufacture and use
09/20/1995EP0672132A1 Receptor internalization signals
09/20/1995EP0672130A1 Peptide corresponding to cd44 exon 6, antibodies specific for said peptide and use of these antibodies for diagnosis of tumors
09/20/1995EP0672068A1 Target binding polypeptide
09/20/1995EP0672061A1 Receptor for oncostatin m and leukemia inhibitory factor
09/20/1995EP0672057A1 Analogs of pth
09/20/1995EP0448635B1 Methods and compositions for the early detection and treatment of insulin dependent diabetes mellitus
09/20/1995CN1108663A Method for preparation of cardiac muscle cell growth stimulus peptide
09/19/1995US5451399 [ALA IL-8]77 and [SER IL-8]72 as Leukocyte adhesion inhibitors
09/14/1995WO1995024427A1 Hybrid human/animal factor viii
09/14/1995WO1995024411A1 Corpuscles of stannius protein, stanniocalcin
09/14/1995WO1995024209A1 Therapeutic uses of bactericidal/permeability-increasing protein dimer products
09/14/1995CA2185327A1 Hybrid human/animal factor viii
09/14/1995CA2184905A1 Corpuscles of stannius protein, stanniocalcin
09/13/1995EP0670730A1 Fusion proteins comprising tumor necrosis factor receptor
09/08/1995WO1995023856A1 Chimeric complement inhibitor proteins
09/08/1995WO1995023814A1 Product and process for t cell regulation
1 ... 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 ... 295